Clinical Trial Update: Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy and safety of fispemifene in hypogonadal men with erectile dysfunction unresponsive to PDE5 inhibitors; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Hypogonadism

Drugs mentioned

• Fispemifene

Snippet

Sponsor: QuatRx Pharmaceuticals Company | Conditions: Hypogonadism, Erectile Dysfunction | Phase 2 | Status: COMPLETED